Melanocortin-3 receptor activates MAP kinase via PI3 kinase
Regulatory Peptides, ISSN: 0167-0115, Vol: 139, Issue: 1, Page: 115-121
2007
- 47Citations
- 33Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations47
- Citation Indexes47
- 47
- CrossRef33
- Captures33
- Readers33
- 33
Article Description
HEK 293 cells stably expressing human melanocortin-3 receptor (MC3R) were exposed to melanocortin receptor agonist, NDP-MSH (10 − 10 –10 − 6 M). ERK1/2 was phosphorylated in a dose-dependent manner with an EC 50 of 3.3 ± 1.5 × 10 − 9 M, similar to the IC 50 of NDP-MSH binding to the MC3R. ERK1/2 phosphorylation was blocked by the melanocortin receptor antagonists SHU9119. NDP-MSH-induced ERK1/2 phosphorylation was sensitive to pertussis toxin and the PI3K inhibitor, wortmannin. Rp-cAMPS, BAPTA-AM and Myr-PKC did not inhibit the NDP-MSH-induced ERK1/2 phosphorylation. NDP-MSH stimulated cellular proliferation in a dose-dependent manner with a similar EC 50 to ERK1/2 phosphorylation, 2.1 ± 0.6 × 10 − 9 M. Cellular proliferation was blocked by AGRP (86–132) and by the MEK inhibitor, PD98059. The NDP-MSH did not inhibit serum deprivation-induced apoptosis. MC3R activation induces ERK1/2 phosphorylation via PI3K and this pathway is involved in cellular proliferation in HEK cells expressing MC3R.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0167011506001911; http://dx.doi.org/10.1016/j.regpep.2006.11.003; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=33846796378&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/17188372; https://linkinghub.elsevier.com/retrieve/pii/S0167011506001911; https://dx.doi.org/10.1016/j.regpep.2006.11.003
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know